Hypertension in pregnancy: Maternal and fetal outcomes according to laboratory and clinical features

Medical Journal of Australia

Volumn 165, Issue 7, 1996, Pages 360-365

  Brown, Mark A ^a,b,c   Buddle, Megan L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Department of Medicine ^*  (Australia)

^c ST GEORGE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; HEMOGLOBIN; SERUM ALBUMIN;

ADULT; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC VALUE; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; FEMALE; FETUS OUTCOME; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MATERNAL HYPERTENSION; MULTIVARIATE ANALYSIS; PARITY; PREECLAMPSIA; PROGNOSIS; PROTEINURIA; SMALL FOR DATE INFANT; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT;

EID: 0029809166     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.1996.tb125017.x     Document Type: Article

References (21)

1. Crawford JS. Epidemic pre-eclampsia. Lancet 1987; 1: 329-330.
2. Tuffnell DJ, Lilford RJ, Buchan PC, et al. Randomised controlled trial of day care for hypertension in pregnancy. Lancet 1992; 339: 224-227.
3. Horvath JS, Korda A, Child A, et al. Hypertension in pregnancy. A study of 142 women presenting before 32 weeks' gestation. Med J Aust 1985; 143:19-21.
4. Clarke M, Mason ES, Macvicar J, Clayton DG. Evaluating perinatal mortality rates: effects of referral and case mix. BMJ 1993, 306: 824-827.
5. Australasian Society for the Study of Hypertension in Pregnancy. Consensus Statement on Management of Hypertension in Pregnancy: Executive Summary. Med J Aust 1993; 158: 700-702.
6. Minitab [computer program], version 9.1. Pennsylvania State College: Minitab Inc, 1993.
7. BMDP [computer program]. Berkeley, Calif: University of California, 1990.
8. Martikainen AM, Heinonen KM, Saarikoski SV. The effect of hypertension in pregnancy on fetal and neonatal condition. Int J Gynaecol Obstet 1989; 30: 213-220.
9. Andrews WW, Cox SM, Sherman ML, Leveno KJ. Maternal and perinatal effects of hypertension at term. J Reprod Med 1992; 37: 73-76.
10. Safflas AF, Oldson DR, Franks AL, et al. Epidemiology of pre-eclampsia and eclampsia in the United States, 1979-1986. Am J Obstet Gynecol 1990; 163: 460-465
11. Pietrantoni M, O'Brien WF The current impact of the hypertensive disorders of pregnancy. Clin Exp Hypertens 1994; 16: 479-492.
12. Hjertberg R, Bellrage P, Hanson U. Conservative treatment of mild and moderate hypertension in pregnancy. Acta Obstet Gynecol Scand 1992; 71: 439-446.
13. Horvath JS, Phippard A, Henderson-Smart D, et al. High risk hypertensive pregnancies: maternal and foetal outcome. Clin Exp Hypertens Pregnancy 1983; B2: 21-28.
14. Brown MA, Buddle ML. The importance of non proteinuric hypertension in pregnancy. Hypertens Pregnancy 1995; 14: 57-65.
15. Pollak VE, Nettles JB. The kidney in toxemia of pregnancy: a clinical and pathologic study based on renal biopsies. Medicine (Baltimore) 1960; 39: 469-526.
16. Redman CWG, Beilin LJ, Bonnar J, Wilkinson PH. Plasma urate measurements in predicting fetal death in hypertensive pregnancy. Lancet 1976; 2: 1370-1373.
17. Chesley LC. Diagnosis of pre-eclampsia. Obstet Gynecol 1985; 65: 423-425.
18. Sibai BM, Taslimi M, Abdella TN, et al. Maternal and perinatal outcome of conservative management of severe pre-eclampsia in midtrimester. Am J Obstet Gynecol 1985; 152: 32-37.
19. Railton A, Allen DG. Management and outcome of pregnancy complicated by severe pre-eclampsia of early onset. S Afr Med J 1987; 72: 608-610.
20. Sibai BM, Mercer BM, Schiff E, Friedman SA. Aggressive versus expectant management of severe pre-eclampsia at 28 to 32 weeks' gestation: a randomized controlled trial. Am J Obstet Gynecol 1994; 171: 818-822.
21. Brown MA, Zammit VC, Mitar DM. Extracellular fluid volumes in pregnancy-induced hypertension. J Hypertens 1992; 10: 821-829.